DNAnexus Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 198
Employees
  • Latest Deal Type
  • Series I
  • Latest Deal Amount
  • $200M
Latest Deal Amount
  • Investors
  • 21

DNAnexus General Information

Description

Developer of a biomedical informatics and data management platform designed to analyze DNA-sequencing data. The company's platform assists researchers across a spectrum of industries like biopharmaceutical, bio agricultural, sequencing services, clinical diagnostics, government, and research consortia to accelerate their genomics programs globally, enabling commercial and academic medical researchers to visualize and analyze big data systems for DNA from a single, unified system.

Contact Information

Website
www.dnanexus.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Database Software
Primary Office
  • 1975 West El Camino Real
  • Suite 204
  • Mountain View, CA 94040
  • United States
+1 (650) 000-0000

DNAnexus Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DNAnexus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series I) 08-Mar-2022 $200M 00000 00000 Completed Generating Revenue
9. Later Stage VC (Series G) 06-Feb-2019 00000 00000 00000 Completed Generating Revenue
8. Later Stage VC (Series F) 02-Jan-2018 0000 00000 00000 Completed Generating Revenue
7. Later Stage VC (Series E) 0000 000.00 00000 Completed
6. Debt - General 01-May-2017 0000 000.00 Completed Generating Revenue
5. Later Stage VC (Series D) 22-Apr-2015 0000 000.00 0000 Completed Generating Revenue
4. Debt - General 21-Mar-2014 000 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 03-Jan-2014 0000 000.00 0000 Completed Startup
2. Early Stage VC (Series B) 12-Oct-2011 $15.2M $16.7M 000.00 Completed Startup
1. Early Stage VC (Series A) 28-Jul-2009 $1.55M $1.55M 00.000 Completed Startup
To view DNAnexus’s complete valuation and funding history, request access »

DNAnexus Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series I 000,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series H 000,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series G 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series F-2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series F-1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series E 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.00
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series B 7,559,292 $0.001000 $0.16 $2.02 $2.02 1x $0.63 2.37%
Series A 1,347,823 $0.001000 $0.09 $1.15 $1.15 1x $0.47 0.32%
To view DNAnexus’s complete cap table history, request access »

DNAnexus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a biomedical informatics and data management platform designed to analyze DNA-sequencing data. The company'
Discovery Tools (Healthcare)
Mountain View, CA
198 As of 2022
00000
0000 0000-00-00
00000000000 00000

00000 00

didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
00000000 00000000
London, United Kingdom
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000

0000000

lor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
0000000000 0000000 (0000000000)
Rijswijk, Netherlands
00 As of 0000
000.00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DNAnexus Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eagle Genomics Venture Capital-Backed London, United Kingdom 00 0000 00000000000 0000
0000000 Formerly VC-backed Rijswijk, Netherlands 00 000.00 000000&0 000.00
00000000 (00000000 Venture Capital-Backed San Diego, CA 00 00.000 000000000 00.000
00000000 Venture Capital-Backed Houston, TX 00 00.000 000000000 00.000
00000000000000 Corporate Backed or Acquired Bangalore, India 00.000 000000000 00.000
You’re viewing 5 of 28 competitors. Get the full list »

DNAnexus Patents

  • 5

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

DNAnexus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170237805-A1 Worker reuse deadline Abandoned 12-Feb-2016 000000000 0
US-20170177597-A1 Biological data systems Abandoned 22-Dec-2015 0
US-20140249761-A1 Characterizing uncharacterized genetic mutations Abandoned 01-Mar-2013 000000000 0
US-20150331909-A1 Application programming interface for tabular genomic datasets Abandoned 20-Dec-2012 0
US-20140244625-A1 Sequence read archive interface Abandoned 12-Aug-2011 G06F16/248 0
To view DNAnexus’s complete patent history, request access »

DNAnexus Executive Team (23)

Name Title Board Seat Contact Info
Richard Daly Chief Executive Officer & Board Member
James McNicholas Chief Financial Officer
George Asimenos Ph.D Chief Technology Officer
Mark Swendsen Chief Revenue Officer
Omar Serang Chief Cloud Officer
You’re viewing 5 of 23 executive team members. Get the full list »

DNAnexus Board Members (13)

Name Representing Role Since
Edward Hu Ph.D WuXi Healthcare Ventures Board Member 000 0000
Ge Li Ph.D WuXi Healthcare Ventures Board Member 000 0000
Geoffrey Duyk Ph.D Self Board Member 000 0000
Hannes Smarason Genuity Science Board Member 000 0000
James Tananbaum MD Foresite Capital Management Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

DNAnexus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DNAnexus Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Blackstone PE/Buyout Minority 000 0000 000000 0
Northpond Ventures Venture Capital Minority 000 0000 000000 0
Perceptive Advisors Hedge Fund Minority 000 0000 000000 0
Innovatus Capital Partners Asset Manager Minority 000 0000 000000 0
Foresite Capital Management Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »

Ready to get started?

Request a free trial